KALA BIO (KALA) director files insider report showing no owned shares

Rhea-AI Filing Summary

KALA BIO, Inc. director Hillel D. Posen filed an initial statement of beneficial ownership as a reporting person. The filing states that no securities of KALA BIO are beneficially owned. It also records that Posen granted a power of attorney authorizing Avraham Minkowitz to sign and file the report on his behalf.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Posen Hillel D.

(Last) (First) (Middle)

1167 MASSACHUSETTS AVENUE

(Street)

ARLINGTON MA 02476

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/30/2026

3. Issuer Name and Ticker or Trading Symbol
KALA BIO, Inc. [ KALA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

The Power of Attorney, executed by the Reporting Person, authorizing Avraham Minkowitz to sign and file this Form 3 on the Reporting Person's behalf is attached hereto as Exhibit 24.

No securities are beneficially owned.

	/s/ Avraham Minkowitz, Attorney-in-Fact	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the initial beneficial ownership report for KALA (KALA BIO, Inc.)?

The initial beneficial ownership report was filed for Hillel D. Posen, a director of KALA BIO, Inc. He is identified as a reporting person but is not listed as an officer or 10% owner in this filing.

What does the KALA (KALA BIO, Inc.) director report about share ownership?

The KALA BIO, Inc. director’s filing states that no securities are beneficially owned. This means the reporting person, Hillel D. Posen, reports holding no direct or indirect ownership of KALA BIO securities as of the event date referenced.

What is the event date in this KALA (KALA BIO, Inc.) insider filing?

The event date requiring the statement is listed as 01/30/2026. This is the date as of which the reporting person’s beneficial ownership status—showing no securities owned—is being reported to regulators.

Who signed the KALA (KALA BIO, Inc.) insider report and in what capacity?

The report is signed “/s/ Avraham Minkowitz, Attorney-in-Fact”. A power of attorney executed by the reporting person authorizes Minkowitz to sign and file the document on Hillel D. Posen’s behalf as attorney-in-fact.

What does the power of attorney note in the KALA (KALA BIO, Inc.) filing explain?

The filing notes that a Power of Attorney executed by the reporting person authorizes Avraham Minkowitz to sign and submit the report. This power of attorney is attached as Exhibit 24, formalizing Minkowitz’s authority to act for the director.